載入...
Sulfonylurea Treatment Before Genetic Testing in Neonatal Diabetes: Pros and Cons
CONTEXT: Diabetes in neonates nearly always has a monogenic etiology. Earlier sulfonylurea therapy can improve glycemic control and potential neurodevelopmental outcomes in children with KCNJ11 or ABCC8 mutations, the most common gene causes. OBJECTIVE: Assess the risks and benefits of initiating su...
Na minha lista:
| 發表在: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255121/ https://ncbi.nlm.nih.gov/pubmed/25238204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2494 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|